Medtronic MDT Insider Ownership

NYSE MDT

$102.86 +1.06 (+1.04%)

As of: Nov 9, 2026 · 12:10 PM EST

Insider Holdings by Owner

1.55Mn Shares

Geoffrey Martha277.87K17.9%

Michael Marinaro113.35K7.3%

Richard H Anderson113.02K7.3%

Brett A. Wall82.18K5.3%

Denise M Oleary77.06K5.0%

Other insiders (28)888.56K57.3%

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

0.097%

▲+0.0033% pp QoQ

Shares Held by Insiders

1.24Mn

filed for Sep 2026

▲+3.42% QoQ

Shares Outstanding

1.28Bn

1,280,046,863 shares

Direct Holdings

1.20Mn

Indirect: 39.80K

Net Open-Market Trades

-4.59K

net sold · -$396.81K in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Open-Market Insider Trades

Bought Sold

Latest quarter —

Net over range —

Net-buying quarters —

Insider Ownership Summary

Updated Nov 5, 2026

In the last 12 months, insiders at Medtronic made open-market sales of $14.67 million (151.72K shares) and bought no shares on the open market.

A count shows 5 insiders selling MDT stock on the open market over the past 12 months and none buying.
Harry Skip Kiil (EVP & President Cardiovascular) was the top open-market seller of Medtronic over the past 12 months, with $5.61 million sold (58.2K shares) and the latest sale on September 16, 2026.
Medtronic's latest insider trade on the open market was a sale of 50K shares for $4.75 million by Geoffrey Martha (Chairman and CEO) on October 15, 2026.
In transactions other than open-market trades, Medtronic insiders received 154.19K shares in stock awards, acquired 217.8K shares through option exercises and conversions, gave up 97.08K shares to cover taxes or exercise prices and gave away 1.11K shares as gifts over the past 12 months.
Per Business Quant, MDT insiders together hold 1.19Mn shares based on their latest Form 4 filings, down 1.00% from 1.2Mn shares at the end of Q2 2026 and down 3.78% from 1.24Mn shares at the end of Q3 2025.
Of the 1.19Mn shares held by Medtronic insiders, 1.15Mn shares (96.66%) are held directly and 39.8K shares (3.34%) indirectly, through trusts, partnerships, family members and other entities.
Per Business Quant, 26 insiders of MDT hold shares, counting officers, directors and 10% owners who have filed a Form 4 in the past two years.
Medtronic's three largest insider shareholders, based on their latest Form 4 filings, are Geoffrey Martha (Chairman and CEO, 277.87K shares), Michael Marinaro (President, 113.35K shares) and Randall J. Hogan (Director, 85.8K shares).
Geoffrey Martha alone accounts for 23.34% of the shares held by Medtronic insiders.
Institutional holders reported 85.19% of Medtronic's outstanding shares for Q2 2026.
Over the trailing 12 months, 21 insiders reported transactions in MDT stock across 52 Form 4 filings.
This summary of Medtronic insider activity covers Form 4 filings through November 4, 2026.

Form 4 Holdings

Insiders Holding MDT

Insiders 33

Shares held 1.55Mn

Of outstanding 0.121%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Geoffrey Martha	Chairman And Ceo	277,866	277,866	17.9%	16 Oct, 2026
2	Michael Marinaro	President	113,353	113,353	7.3%	04 Nov, 2026
3	Richard H Anderson	Director	113,023	113,023	7.3%	03 May, 2023
4	Brett A. Wall	Evp Pres Neuroscience	82,183	82,183	5.3%	28 May, 2026
5	Denise M Oleary	Director	77,057	77,057	5.0%	03 May, 2024
6	Sean Salmon	Evp President Cardiovascular	64,722	64,722	4.2%	17 Dec, 2024
7	Ivan K Fong	Evp General Counsel Secr	54,692	54,692	3.5%	17 Dec, 2024
8	Hoedt Rob Ten	Evp And Pres. Global Regions	52,748	52,748	3.4%	07 Aug, 2023
9	Kendall J Powell	Director	51,380	51,380	3.3%	29 Apr, 2026
10	Thierry Pieton	Evp Chief Financial Officer	49,645	49,645	3.2%	04 Aug, 2026
11	Randall J Hogan	Director	48,998	48,998	3.2%	29 Apr, 2026
12	Robert John White	Evp Pres. Medical Surgical	48,410	48,410	3.1%	12 Dec, 2023
13	Karen L Parkhill	Evp Chief Financial Officer	46,730	46,730	3.0%	06 Aug, 2024
14	Gregory L Smith	Evp Global Ops Supply Chain	46,016	46,016	3.0%	21 Nov, 2025
15	Gary Louis Corona	Interim Cfo	44,255	44,255	2.9%	23 Jan, 2025
16	Harry Skip Kiil	Evp President Cardiovascular	42,186	42,186	2.7%	17 Sep, 2026
17	Craig Arnold	Director	42,185	42,185	2.7%	29 Apr, 2026
18	Matthew R. Walter	Svp, Chief Hr Officer	39,928	39,928	2.6%	04 Aug, 2026
19	John R Liddicoat	Evp President Of Americas	37,374	37,374	2.4%	02 Aug, 2022
20	Kweli Thompson	Evp President, Neuroscience	35,390	35,390	2.3%	04 Aug, 2026
21	Jennifer M Kirk	Chief Accounting Officer	28,011	28,011	1.8%	10 Dec, 2024
22	Michelle Quinn	Evp, Gc And Secretary	26,721	26,721	1.7%	04 Aug, 2026
23	Carol A Surface	Evp, Chief Hr Officer	26,193	26,193	1.7%	03 Aug, 2022
24	Scott C Donnelly	Director	23,679	23,679	1.5%	29 Apr, 2026
25	Elizabeth G Nabel	Director	19,584	19,584	1.3%	29 Apr, 2026
26	Denise L. Blomquist	Chief Accounting Officer	16,398	16,398	1.1%	16 Sep, 2026
27	Andrea Jo Goldsmith	Director	10,247	10,247	0.7%	30 Apr, 2025
28	Kevin E Lofton	Director	9,977	9,977	0.6%	21 Oct, 2026
29	Lidia Fonseca	Director	7,644	7,644	0.5%	29 Apr, 2026
30	William R Jellison	Director	6,444	6,444	0.4%	29 Apr, 2026
31	Gregory P Lewis	Director	5,754	5,754	0.4%	29 Apr, 2026
32	Joon Sup Lee	Director	1,803	1,803	0.1%	29 Apr, 2026
33	John P Groetelaars	Director	1,444	1,444	0.1%	29 Apr, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

1,663 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
02 Nov, 2026	Michael Marinaro	President	Acquired A	6,547	$0.00	$0	113,353	Direct
02 Nov, 2026	Michael Marinaro	President	Acquired A	16,367	$0.00	$0	16,367	Direct
02 Nov, 2026	Michael Marinaro	President	Acquired A	42,994	$0.00	$0	42,994	Direct
15 Oct, 2026	Kevin E Lofton	Director	Disposed J	182	—	—	9,977	Direct
15 Oct, 2026	Geoffrey Martha	Chairman And Ceo	Disposed S	50,000	$95.00	$4.75Mn	277,866	Direct
15 Oct, 2026	Michael Marinaro	Evp, Pres Medsurg And Americas	Disposed S	10,420	$96.00	$1.00Mn	105,916	Direct
16 Sep, 2026	Harry Skip Kiil	Evp President Cardiovascular	Disposed S	1,483	$93.65	$138.88K	42,186	Direct
15 Sep, 2026	Denise L. Blomquist	Chief Accounting Officer	Disposed G	600	$0.00	$0	16,398	Direct
20 Aug, 2026	Michael Marinaro	Evp, Pres Medsurg And Americas	Disposed F	1,084	$92.30	$100.05K	116,336	Direct
31 Jul, 2026	Matthew R. Walter	Svp, Chief Hr Officer	Disposed F	1,675	$85.39	$143.03K	34,159	Direct
31 Jul, 2026	Michael Marinaro	Evp, Pres Medsurg And Americas	Disposed F	3,356	$85.39	$286.57K	60,313	Direct
31 Jul, 2026	Kweli Thompson	Evp President, Neuroscience	Disposed F	1,739	$85.39	$148.49K	28,467	Direct
31 Jul, 2026	Harry Skip Kiil	Evp President Cardiovascular	Disposed F	3,074	$85.39	$262.49K	34,439	Direct
31 Jul, 2026	Geoffrey Martha	Chairman And Ceo	Disposed F	15,810	$85.39	$1.35Mn	286,333	Direct
03 Aug, 2026	Michelle Quinn	Evp, Gc And Secretary	Acquired A	6,346	$0.00	$0	26,721	Direct
31 Jul, 2026	Denise L. Blomquist	Chief Accounting Officer	Disposed F	212	$85.39	$18.10K	14,661	Direct
03 Aug, 2026	Thierry Pieton	Evp Chief Financial Officer	Acquired A	11,537	$0.00	$0	49,645	Direct
03 Aug, 2026	Harry Skip Kiil	Evp President Cardiovascular	Acquired A	9,230	$0.00	$0	43,669	Direct
03 Aug, 2026	Michael Marinaro	Evp, Pres Medsurg And Americas	Acquired A	10,960	$0.00	$0	71,273	Direct
03 Aug, 2026	Geoffrey Martha	Chairman And Ceo	Acquired A	41,533	$0.00	$0	327,866	Direct

Showing 1 to 20 of 1,663 transactions